Streamlined genetic testing pathway is developed for women with ovarian cancerBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3900 (Published 14 July 2016) Cite this as: BMJ 2016;354:i3900
- Jacqui Wise
The Royal Marsden Hospital in London has been trialling a new gene testing pathway for women with ovarian cancer, which makes the process faster and simpler and allows women to receive personalised treatment promptly.
The pilot study, published in the journal Scientific Reports,1 included 207 women with ovarian cancer who were offered BRCA gene testing at one of their routine cancer clinic appointments instead of referral to a separate genetic testing clinic.
Testing was carried out by a doctor or nurse in a 30 minute …